Skip to main content
. 2021 Jun 29;46(12):2090–2100. doi: 10.1038/s41386-021-01064-9

Fig. 4. Everolimus pre treatment reverses incubation-related changes in mGlu1/5 expression within the PL.

Fig. 4

The immunoblotting results for the expression of the monomer and dimer forms of mGlu1 and mGlu5 within the PL are presented in the left panels. For direct comparison, the results for the IL are presented in the right panels. ad In the PL, a non-significant reduction in the expression of both the dimer and monomer forms of each receptor was observed in 30WD-VEH vs. 3WD-VEH controls. Relative to 30WD-VEH rats, everolimus increased mGlu1/5 expression in rats tested on WD30. eh Relative to 3WD-VEH controls, 30WD-VEH rats exhibited a significant increase in the IL levels of the mGlu1 monomer only. Everolimus significantly elevated IL levels of the mGlu1 dimer in rats tested on 30WD, with no other significant changes in protein expression detected in this subregion. As indicated in a, the data are presented as box plots in which the mean is represented by, the median by —, outliers are indicated by ♦’s, the box represents the interquartile range (IQR) and the error bars represent 1.5 X IQR (see d). *p < 0.05 WD3-VEH vs. WD30-VEH (incubation); +p < 0.05 30WD-VEH vs. 30WD-E1.0 (Everolimus effect) as determined by Tukey–Kramer comparisons corrected for multiple comparisons.